Alpha Biotica - Company finances
|
EUR
|
2024
From: 2024-09-03
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 56,710 | 251,419 |
| Profit before tax | 11,508 | 37,988 |
| Net profit | 11,508 | 31,832 |
| Equity | 11,509 | 43,341 |
| Liabilities | 8,337 | 82,443 |
| Non-current assets | 0 | 0 |
| Current assets | 19,643 | 125,321 |
| Total assets | 19,643 | 125,321 |
|
Taxes paid
|
||
| STI taxes | 5,020 | 52,479 |
|
Financial indicators
|
||
| Revenue change y/y | - | +343.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 58.6% | 25.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 73.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 20.3% | 12.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 20.3% | 15.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 1.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 251,419 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Alpha Biotica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-23 | 858.49 |
| 2026-07-16 | 2026-07-17 | 858.49 |
Alpha Biotica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-12 | 2026-08-13 | 0.49 |
| 2026-08-02 | 2026-08-09 | 36.47 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Alpha Biotica, UAB (code 306984228) is a Private Limited Liability Company active in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €251.4K and net profit of €31.8K, with a profit margin of 12.7%. Revenue increased by 343.3% year on year, reflecting a strong expansion from €56.7K in 2024, when the reporting period covered 119 days, to a full 364-day year in 2025. Net profit also improved from €11.5K in 2024 to €31.8K in 2025. At year-end 2025, total assets stood at €125.3K, equity at €43.3K, and liabilities at €82.4K. The equity ratio was 34.6% and debt-to-equity was 1.90, indicating a materially leveraged but still equity-backed balance sheet. Asset turnover reached 2.01x, ROE was 73.5%, and ROA was 25.4%. Revenue per employee was €251.4K and profit per employee was €31.8K, pointing to high operating productivity.